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Abstract
Objectives To assess whether digital X-ray radiogrammetry
(DXR) analysis of standard clinical hand or wrist radio-
graphs obtained at emergency hospitals can predict hip
fracture risk.
Methods A total of 45,538 radiographs depicting the left
hand were gathered from three emergency hospitals in
Stockholm, Sweden. Radiographs with insufficiently in-
cluded metacarpal bone, fractures in measurement regions,
foreign material or unacceptable positioning were manually
excluded. A total of 18,824 radiographs from 15,072
patients were analysed with DXR, yielding a calculated
BMD equivalent (DXR-BMD). Patients were matched with
the national death and inpatient registers. Inclusion criteria
were age ≥ 40 years, no prior hip fracture and observation
time > 7 days. Hip fractures were identified via ICD-10
codes. Age-adjusted hazard ratio per standard deviation
(HR/SD) was calculated using Cox regression.
Results 8,257 patients (65.6 % female, 34.4 % male) met
the inclusion criteria. One hundred twenty-two patients suf-
fered a hip fracture after their radiograph. The fracture group
had a significantly lower DXR-BMD than the non-fracture
group when adjusted for age. The HR/SD for hip fracture
was 2.52 and 2.08 in women and men respectively. The area
under the curve was 0.89 in women and 0.84 in men.
Conclusions DXR analysis of wrist and hand radiographs
obtained at emergency hospitals predicts hip fracture risk in
women and men.
Key Points
• Digital X-ray radiogrammetry of emergency hand/wrist
radiographs predicts hip fracture risk.
• Digital X-ray radiogrammetry (DXR) predicts hip fracture
risk in both women and men.
• Osteoporosis can potentially be identified in patients with
suspected wrist fractures.
• DXR can potentially be used for selective osteoporosis
screening.
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Introduction
According to epidemiological studies, about one third of wom-
en over 50 years of age will experience a fragility fracture [1,
2]. The number of fractures can be reduced by adequate meas-
ures, such as lifestyle adaptations [3–6] and pharmaceutical
interventions [7–10]. To be cost effective and avoid unneces-
sary and potentially harmful pharmaceutical treatment, it is
imperative that those at risk are properly identified and targeted.
Previous studies have shown a correlation between bone
mineral density (BMD) and the risk of fracture [11–15].
Consequently, BMD measurement has a prominent position
in fracture risk assessment and diagnosis of osteoporosis.
Dual-energy X-ray absorptiometry (DXA) of the hip or
spine is considered the gold standard [12, 15, 16]. Unfortu-
nately, most patients with a high risk of osteoporosis are not
scanned by DXA, even when the clinician suspects osteo-
porosis. This is due to the relatively high costs [17, 18] and
low availability of equipment [19–22].
Digital X-ray radiogrammetry (DXR) is a peripheral
measurement method based on a combination of an average
geometrical measure of the cortical thickness of metacarpals
II-IV and structural analysis of cortical bone porosity [23,
24]. The analysis is based on a standard radiograph of the
hand (Fig. 1) and gives a computed BMD equivalent mea-
surement. This makes DXR an interesting and potentially
cost-effective candidate for the evaluation of osteoporosis-
related fracture risk.
The objective of this study was to assess whether DXR
analysis can predict hip fracture risk by using standard clinical
hand or wrist radiographs obtained at emergency hospitals.
Materials and methods
This cohort study includes data from 1 January 2000 to 31
December 2008. The data were retrieved in 2009 and 2010.
The ethical committee in Stockholm approved the study.
Fig. 1 Wrist radiographs used
for DXR analysis of patients
with varying DXR T-scores.
Measurement regions are indi-
cated over metacarpals II-IV.
Patient 1: a 50-year-old woman.
DXR T-score 1.18. DXR-BMD
0.64 g/cm2. Patient 2: a
48-year-old woman. DXR
T-score −1.90. DXR-BMD
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Radiograph selection
Database queries based on examination codes were used to
extract all left hand and wrist radiographs from the digital
archives of three major emergency hospitals in the Stock-
holm region. Clinical indications for left hand or wrist radio-
graphs included suspicion of fracture, luxation, foreign body
or arthritis.
A total of 45,538 radiographs were extracted from the
digital archives. All measurements and radiographs were
manually reviewed by two of the investigators, who were
blinded to all clinical information, and assessed according to
suitability for further DXR analysis. Inclusion criteria were
radiographs of the left hand or wrist depicting sufficient
metacarpal bone for DXR analysis. Exclusion criteria were
fractures in the measurement regions, foreign material
such as fixation pins and plaster, or unacceptable posi-
tioning of the metacarpals. In all, 18,824 examinations
from 15,072 patients were considered suitable for DXR
analysis. In patients with repeated examinations, only the
chronologically first evaluable examination was used. The
image and patient selection process is illustrated in a flow
chart (Fig. 2).
Patient selection
All patients whose radiographs were included for DXR
analysis were identified in the National Patient Register
provided by the National Board of Health and Welfare.
Patients who subsequently had a hip fracture were identi-
fied via ICD-10 codes (S72.0, S72.1, S72.2). Inclusion
criteria were age >40 years, no hip fracture prior to
acquisition of the radiograph and observation time >7 days.
To minimise the risk of erroneous registrations, only those
coded for both diagnosis and adequate intervention (either
upper femur fracture surgery or hip replacement, i.e. ICD-
10 surgical codes NFJ and NFB) were registered as hip
fracture. In order not to exclude patients with a hip
fracture who were too critically ill for surgery, patients
who died within 3 days after a registered fracture were
also included. Date of fracture diagnosis, date of death or
study end date (31 December 2008) was used as censor-
ing time. The National Cause of Death Register provided
date of death.
Digital X-ray radiogrammetry and BMD
Digital X-ray radiogrammetry (DXR) (Onescreen, Sectra
Imtec AB, Linköping, Sweden) is a development of the
traditional technique of radiogrammetry. On a standard
projection radiograph, measurement regions are automati-
cally placed around the narrowest parts of metacarpals II-
IV. A BMD equivalent measurement (DXR-BMD) is then
computed. The calculation is defined as DXR-BMD 0 cxVPAx
(1-p) where c is a density constant empirically determined so
that DXR-BMD on average is equal to the mid-distal forearm
region of the Hologic QDR-2000 densitometer (Hologic, Bed-
ford,MA, USA),VPA is cortical bone volume per area and p is
porosity. When comparing an individual’s DXR-BMD to the
mean DXR-BMD of a young, healthy, normal reference pop-
ulation, a DXR T-score can be derived. When compared to a
healthy reference population of the same age, a DXR Z-score
is obtained.
Any digital or CR radiography equipment that is appli-
cable for acquiring hand X-ray images can be used to
acquire images for DXR-BMD analysis. The DXR analysis
process is automated and operator independent. However,
there are some requirements about positioning and exposure
settings, e.g., when acquiring radiographs intended for
DXR analysis. Some requirements are generic (posterior-
anterior X-ray image of one hand, palm flat to detector
table/image plate surface, focus centred on metacarpal III)
and some are specific per modality type and model (image
postprocessing settings, focus distance, exposure settings,
location on detector).
The DXR technology has been described in more detail
previously [23, 24], and normative reference tables have
been published [25, 26].
Fig. 2 Flow chart of how
radiographs and patients were
selected (gray 0 inclusion,
red 0 exclusion)
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Statistical analysis
Group comparisons were made using Student’s t-test for
continuous normally distributed data. Receiver-operator
characteristics (ROC) were plotted (Fig. 3) to evaluate the
predictive value of the DXR T-score to assess fracture risk.
In these graphs the sensitivity of a parameter, in this case
DXR T-score, to predict future fractures is plotted as a
function of the proportion of false positives (1-specificity).
To compensate for age-related fracture risk that is not related
to DXR-BMD (e.g. the increased tendency to fall), the
ROCs were adjusted for age. To enable comparison among
different studies, the area under the plotted age-adjusted
ROC curve, the AUC and the age-adjusted hazard ratio per
standard deviation change in DXR T-score (HR/SD) were
calculated. The HR/SD was calculated using Cox regression
and the risk of sustaining a hip fracture at DXRT-scores >−1
was defined as risk 0 1. SAS® 9.2 (SAS Institute, Cary, NC)
was used for the statistical analysis.
Results
The inclusion criteria were met by 8,257 patients (65.6 %
women; 34.4 % men). The average age was 59.6 years (SD
12) (60.5 years in women; 57.8 years in men). The average
follow-up period was 3 years 3 months with a total obser-
vation time of 27,072 person-years. The number of patients,
average DXR-BMD, DXR T-score, number of fractures and
annual fracture rate are provided per 5-year age group in
Table 1 and per DXR T-score in Table 2.
During the observation period, 122 patients (89 women
and 33 men) suffered from a hip fracture. In both men and
women, the patients who suffered from a hip fracture were
significantly older at the time of X-ray examination and had
a significantly lower DXR-BMD, DXRT-score and DXR Z-
score than those who did not (Table 3). Out of the 122
patients who suffered a hip fracture, 84 (72 women and 12
men, 69 %) had a DXR T-score of ≤−2.5, resulting in a
sensitivity of 81 % and a specificity of 79 % in women and
36 % and 93 % respectively in men (Table 4).
The age-adjusted AUC for the DXR T-score to predict
hip fracture was 0.89 in women and 0.84 in men (Fig. 3). In
the 55–85-year age group, the corresponding AUCs were
0.83 and 0.80, respectively.
Age-adjusted hazard ratios for hip fracture at different
DXR T-scores are shown in Fig. 4 and Table 5. The hazard
ratio per standard deviation change in DXR T-score (HR/
SD) for hip fracture was 2.52 and 2.08 in the female and
male group, respectively. In the 55–85-year age group, the
corresponding values were 2.33 and 2.00 for women and
men, respectively.
Discussion
In this study, DXR-BMD of archived radiographs of the
wrist or hand were used to evaluate the association with
hip fractures occurring after the radiograph had been
obtained. In order to evaluate whether DXR of radiographs
of the wrist and hand obtained at emergency hospitals can
be used for selected screening for osteoporosis, so-called
area under the curve (AUC) calculations were made. Those
Fig. 3 a Age-adjusted ROC curve for women. b Age-adjusted ROC
curve for men
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describe the relationship between the sensitivity and speci-
ficity. Ideally such curves are close to 1, where only those
who will suffer from a hip fracture are discriminated from
those who will not. In this study, the age-adjusted AUC for
the DXR T-score to predict hip fracture was 0.89 in women
and 0.84 in men. These values are similar to, or higher than,
those previously published for central DXA [14]. Bousson
et al. compared quantitative computed tomography (QCT)
and hip DXA in a female study population with a similar
age distribution to our cohort and obtained AUCs almost as
large as ours (0.84 for QCT and 0.80 for DXA) [27]. In the
EPIDOS cohort, AUC calculations for hip fracture risk
based on central DXA measurements ranged from 0.68 to
0.72 depending on the region measured [15]. However, the
EPIDOS population was older and the age distribution
smaller (average age 80.5, SD 3.8), which results in smaller
AUCs. Cummings’ study, based on a younger population
(average age 73.2) than the EPIDOS cohort, provided a
slightly greater AUC, with a maximum of 0.78 for women
undergoing DXA of Ward’s triangle (AUC was 0.76 when
measured at the femoral neck) [28].
A meta-analysis from 1996 estimated that the increased
risk of hip fracture with a decrease of 1.0 in T-score is 2.6
for hip BMD and 1.9 for lumbar spine BMD in women [29].
Later studies have shown similar results [13, 30]. When
using DXR, Bouxsein et al. reported a hazard ratio per
decrease of 1.0 in DXR T-score of 1.8 for hip fractures in
a case-cohort study of a sample from the Study of Osteopo-
rotic Fracture (SOF) cohort, i.e., community-dwelling US
women aged >65 years [31]. In their prospective study DXR
compared well to other peripheral BMD measurements, but
was inferior to central BMD measurements when predicting
hip fracture risk. In a DXR analysis of archived radiographs
from a subgroup of the Copenhagen City Heart Study co-
hort, consisting of women >55 years with self-reported joint
or bone pain, Bach-Mortensen et al. reported a HR/SD of
1.4 for hip fractures (P00.052) [32].
In our study the HR/SD for DXR in women aged 55–
85 was 2.33 and in all women 2.52. Thus, DXR provided
predictive values comparable to those previously pub-
lished for central BMD measurements [29] and consider-
ably higher than those previously reported for DXR [31,
32]. However, our study differs from the previous studies
by Bouxsein’s and Bach-Mortensen’s groups with regard
to the study population. Their studies included patients
recruited from selected cohorts (SOF cohort and Copen-
hagen City Heart Study cohort, respectively). Our study
reflects all patients undergoing standard X-ray examina-
tion of the left hand at three emergency hospitals in
Stockholm. These groups might differ in terms of fracture
and disease prevalence. The hazard ratio was also high in the
male group; 2.08 in all men and 2.00 in men aged 55–85. To
our knowledge, DXR’s predictability has not previously been
studied in men.
Due to the inclusion of all left hand/wrist radiographs
obtained at three emergency hospitals, the patients included
were most likely those with a suspected wrist fracture, i.e.
trauma, and patients undergoing routine control for rheuma-
toid arthritis. Distal forearm fractures have been shown to be
associated with other fragility fractures and have therefore
been suggested as a possible predictor in fracture risk as-
sessment [12, 33–35]. The correlation between wrist frac-
ture and other fragility fractures appears to be stronger in
men [36]. Rheumatoid arthritis has been shown to increase
Table 1 Distribution of numbers, bone mineral density (DXR-BMD), DXR T-score and fracture rate by 5-year age groups
Age Number Mean DXR-BMD (standard
deviation)
Mean DXR T-score (standard deviation) Fractures Mean annual fracture rate (%)
Female Male Female Male Female Male Female Male Female Male
40–44 523 472 0.59 (0.05) 0.66 (0.06) 0.19 (1.14) −0.20 (1.01) 0 1 0.00 0.07
45–49 598 424 0.58 (0.05) 0.66 (0.06) 0.01 (1.08) −0.27 (1.02) 1 2 0.05 0.14
50–54 747 404 0.56 (0.05) 0.65 (0.06) −0.43 (1.15) −0.41 (1.02) 1 3 0.04 0.23
55–59 982 426 0.55 (0.05) 0.64 (0.06) −0.78 (1.14) −0.53 (0.99) 2 4 0.06 0.27
60–64 847 360 0.52 (0.06) 0.63 (0.06) −1.33 (1.18) −0.69 (0.97) 8 5 0.29 0.45
65–69 558 239 0.50 (0.06) 0.60 (0.06) −1.80 (1.27) −1.11 (1.01) 8 0 0.44 0.00
70–74 403 192 0.47 (0.06) 0.59 (0.07) −2.35 (1.21) −1.39 (1.10) 9 2 0.67 0.35
75–79 338 154 0.44 (0.06) 0.58 (0.07) −2.93 (1.18) −1.54 (1.11) 17 4 1.47 0.92
80–84 260 104 0.43 (0.06) 0.56 (0.07) −3.24 (1.16) −1.91 (1.17) 18 5 2.19 1.63
85–89 116 48 0.41 (0.05) 0.53 (0.06) −3.74 (1.00) −2.37 (0.98) 18 4 6.90 3.78
90–94 38 12 0.39 (0.05) 0.48 (0.07) −4.10 (1.05) −3.06 (1.16) 7 2 9.83 14.63
95–99 10 2 0.37 (0.04) 0.49 (0.05) −4.49 (0.85) −2.93 (0.88) 0 1 0.00 98.98
Total 5420 2837 0.53 (0.08) 0.63 (0.07) −1.20 (1.60) −0.69 (1.16) 89 33 0.49 0.37
Eur Radiol (2013) 23:1383–1391 1387
the risk of fracture significantly [30, 37, 38]. Hence, the
patients in our study were most likely at higher risk of
fragility fractures than a normal population. This might also
explain the improved performance of DXR observed in our
study compared to previous reports [31, 32].
Defining clinical thresholds
There are no previous recommendations on when patients
should receive treatment based on DXR measurements.
According to the National Osteoporosis Foundation clini-
cian’s guide to prevention and treatment of osteoporosis,
health-care providers should consider FDA-approved med-
ical therapies in postmenopausal women and men aged
50 years and older at T-score ≤−2.5 at the femoral neck or
spine or in the case of low bone mass (T-score between −1.0
and −2.5 at the femoral neck or spine) and a 10-year prob-
ability of a hip fracture ≥3 % [39]. In clinical fracture
outcome trials, a T-score of −2.5 is one of the most com-
monly used inclusion criteria, for example in the FREE-
DOM trial [40]. A combination of low BMD and
prevalent vertebral fracture has also been used for inclusion.
In the HORIZON trial subjects could be included if they had
femoral neck BMD with a T-score of ≤−2.5 or if they had a
T-score of ≤−1.5 plus at least two prevalent vertebral frac-
tures [41]. When calculating the annual hip fracture rate in
women receiving a placebo during those two clinical trials,
the rate was 0.37 % and 0.76 % respectively. If the threshold
DXRT-score ≤−2.5 is applied for all women in our material,
the sensitivity to find hip fractures would be 0.81 and the
specificity 0.79. However, in guidelines treatment is nor-
mally recommended for the 55–85-year age group. Used in
that age group, the threshold DXR T-score ≤−2.5 would
result in a sensitivity of 0.76 and a specificity of 0.72, with
an annual fracture rate of 1.6 %. That rate is clearly higher
than those observed in most pivotal fracture trials. This
higher fracture incidence illustrates the difference in fracture
incidence between clinical cohorts and that of clinical trials
Table 3 Differences between
fracture and non-fracture groups
by sex. One standard deviation is
given within parentheses. All
differences were statistically
significant at the P < 0.001 level
Number Age at exam (years) DXR-BMD (g/cm2) DXR T-score DXR Z-score
Female
Fracture 89 78 (10) 0.419 (0.05) −3.5 (1.1) −0.565 (0.988)
Non-fracture 5,331 60 (12) 0.528 (0.08) −1.2 (1.6) 0.009 (0.997)
Male
Fracture 33 70 (16) 0.538 (0.09) −2.2 (1.4) −0.900 (1.110)
Non-fracture 2,804 58 (12) 0.630 (0.07) −0.7 (1.1) 0.030 (0.994)














<−6 5 74.9 12.0 1 18 5.71
−6<−5 44 83.5 8.8 5 121 4.12
−5<−4 235 78.7 8.9 23 698 3.30
−4<−3 516 74.2 9.4 40 1,573 2.54
−3<−2 803 66.9 9.6 10 2,634 0.38
−2<−1 1,172 61.0 9.3 6 3,834 0.16
−1<0 1,376 55.9 8.3 4 4,733 0.08
0<1 870 52.1 7.5 0 3,006 0.00
1<2 336 49.9 7.1 0 1,238 0.00
2<3 57 47.4 11.0 0 211 0.00
3<4 4 46.7 7.5 0 10 0.00
4<5 2 51.5 11.5 0 8 0.00
Total 5,420 60.5 12.0 89 18,083 0.49
<−2.5 1,165 73.6 10.2 72 3,581 2.01
Male
<−6 1 81.0 – 1 5 19.50
−6<−5 – – – – – –
−5<−4 16 74.6 11.3 0 42 0.00
−4<−3 81 74.1 12.8 8 217 3.68
−3<−2 264 67.7 12.9 9 768 1.17
−2<−1 679 61.0 12.3 9 2,070 0.43
−1<0 1,011 55.8 10.6 4 3,296 0.12
0<1 610 53.1 9.1 1 1,959 0.05
1<2 157 49.9 8.2 1 562 0.18
2<3 18 46.7 5.2 0 69 0.00
3<4 – – – – – –
4<5 – – – – – –
Total 2,837 57.8 12.2 33 8,989 0.37
<−2.5 199 72.1 12.5 12 553 2.17
Table 4 The sensitivity and specificity of DXR to predict hip fracture
at DXR T-score ≤−2.5, with 95 % confidence intervals and the









Women >40 81 (73–89) 79 (78–80) 2.01
55–85 76 (66–86) 72 (70–73) 1.62
Men >40 36 (20–53) 93 (92–94) 2.17
55–85 25 (6–44) 90 (89–92) 1.18
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with selected subjects. It can therefore be discussed whether
treatment should be given at higher DXRT-scores than <−2.5
in order to give treatment at the same fracture risk level as
those shown to be efficient in the clinical trials. However, if
the threshold were based on annual hip fracture rates similar to
those observed in the placebo group of the HORIZON trial
(0.76 %) [41], it would result in a severely reduced specificity.
Women aged 55 to 85 would then receive treatment already
at DXR T-scores of ≤−0.59, resulting in a sensitivity of
0.97, but with the poor specificity of 0.23. This would lead
to substantially higher numbers needed to treat in order to
avoid one hip fracture.
Defining the threshold level for men is more challenging.
At DXRT-score <−2.5 the sensitivity for all men >40 years is
only 0.36 and specificity 0.93, with an annual fracture rate of
2.0 %. Applying a threshold of DXR T-score <−2.5 would
therefore imply severe undertreatment, excluding most men at
risk. In men the threshold value of osteopenia seems more
reasonable when applied to the 55–85-year age group, result-
ing in a sensitivity of 0.52 and specificity of 0.76, with an
annual hip fracture rate of 0.81 %. However, there were only
20 hip fractures in that age group, so the threshold for treat-
ment in men when using DXR cannot be robustly estimated.
Study limitations
The radiographs used in this study were not intentionally
intended for DXR analysis. Only 41 % of the retrieved
radiographs were considered suitable for analysis with
DXR. This percentage might appear small, but one has to
consider that all radiographs with plaster, external fixation
or fractures that affected the metacarpals (i.e. measurement
regions) were excluded. When retrieving radiographs from
the digital archives, examinations of fingers or carpal bones
were also included as they carry the same examination code
as a radiograph of the hand. Such radiographs could not be
included as they do not fully depict the metacarpal bones.
In some included cases, the radiographs considered accept-
able for DXR analysis were actually slightly suboptimal be-
cause they were not obtained according to the DXR protocol.
This source of error might affect DXR’s predictive value in
this study.
According to population registers from Statistics Swe-
den, 78 % of the population in Stockholm was born in
Sweden, 15 % in other Caucasian countries, 2.6 % in Asian
countries, 2.2 % in African countries and 1.7 % in Hispanic
countries. Due to the retrospective data collection of radio-
graphs only, there was no information on patient race, body
mass index or menopause age. Neither were there records on
prior or subsequent treatment for osteoporosis or other dis-
eases. This could influence the predictive value found in this
study. If a great proportion of our material had treatment
with cytostatics or corticosteroids, this would lead to an
overestimation of the predictive value, but on the other hand
osteoporosis treatment would lead to an underestimation.
The DXR analysis is intended for use on the non-
dominant hand. As there was no patient record regarding
hand dominance, the left hand was analysed in all patients.
Approximately 10 % of the population has a left hand
dominance [42]. This is a source of error, probably resulting
in slightly higher DXR-BMD in left-dominant individuals,
which could lead to a slight underestimation of DXR’s
ability to predict future hip fractures.
The use of The Swedish National Patient Register and
National Cause of Death Register minimised the risk of loss
to follow-up. This is a major strength of this study due to the
high quality of the registers with 99 % completion [43].
Unfortunately, we were not able to identify whether any of
the patients had been exposed to high-energy trauma that
could have caused their hip fracture. This is a limitation of
Fig. 4 Hazard ratio by various DXR T-scores for female and male
subjects. No data shown for men at DXR T-score <−4 because of
insufficient numbers of subjects
Table 5 Age-adjusted hazard ratios for hip fracture for different DXR











<−2 to −1 2.1 0.56 7.7 1,172 6 3,834
<−3 to −2 3.1 0.87 10.8 803 10 2,634
<−4 to −3 14.4 4.42 47.2 516 40 1,573
<−5 to −4 15.7 4.59 53.8 235 23 698
<−5 18.3 4.45 74.8 49 6 139
Male
<−2 to −1 3.5 1.20 10.1 679 9 2,070
<−3 to −2 6.3 2.01 19.6 264 9 768
<−4 to −3 16.7 4.99 56.1 81 8 217
<−5 to −4 0.00 0.00 – 16 0 42
<−5 42.3 4.30 416.4 1 1 5
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our study as non-fragility fractures might have been includ-
ed in the fracture group. However, this effect is believed to
be minimal, as patients with hip fractures were on average
significantly older than those without fracture and had lower
DXR-BMD. Furthermore, included non-fragility, i.e. high-
energy trauma, hip fractures would most likely affect DXR’s
predictive ability unfavorably, resulting in an underestima-
tion of the method’s predictive value.
In conclusion, hip fractures can be predicted in both
women and men by DXR analysis of clinical wrist and hand
radiographs obtained at emergency hospitals. DXR may
therefore be useful to identify patients with increased hip
fracture risk already at the emergency department and might
provide an alternative where access to central BMD meas-
urements is limited. However, further studies are warranted
to determine DXR’s ability in a normal population.
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